Consumer Health in France
At first glance, consumer health in France appears to exhibit robust current value growth in 2024, similar to the performance observed in 2023. However, industry players express considerable disappointment regarding volume progression. In light of a challenging economic environment, French households are increasingly favouring prescribed OTC products in order to benefit from reimbursement. This shift positively impacts pure OTC products but does not translate into sufficient volume growth. Value...
Euromonitor International's Consumer Health in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Consumer Health in France
- Euromonitor International
- September 2024
- List Of Contents And Tables
- CONSUMER HEALTH IN FRANCE
- EXECUTIVE SUMMARY
- Consumer health in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
- Table 2 Life Expectancy at Birth 2019-2024
- MARKET DATA
- Table 3 Sales of Consumer Health by Category: Value 2019-2024
- Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024
- Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024
- Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024
- Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
- Table 8 Distribution of Consumer Health by Format: % Value 2019-2024
- Table 9 Distribution of Consumer Health by Format and Category: % Value 2024
- Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029
- Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
- ANALGESICS IN FRANCE
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Analgesics beset by challenges in 2024
- Despite the popularity of acetaminophen, ibuprofen’s woes erode overall category potential
- Doliprane’s popularity consolidates Sanofi’s leadership position, while consumers fret over dearth of medical professionals
- PROSPECTS AND OPPORTUNITIES
- Self-medication on the rise, but uncertainty around pseudoephedrine dampens expectations for overall category
- Retailers and manufacturers look to avoid shortages
- Sanofi to divest itself of consumer health arm
- CATEGORY DATA
- Table 12 Sales of Analgesics by Category: Value 2019-2024
- Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024
- Table 14 NBO Company Shares of Analgesics: % Value 2020-2024
- Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024
- Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029
- Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
- COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN FRANCE
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- 2024 sees modest sales performance
- Combination products witness another year of double-digit decline amid pseudoephedrine controversy
- Ricola benefits from French consumers’ sweet tooth
- PROSPECTS AND OPPORTUNITIES
- As flu seasons settle down the impact will be offset by rising demand for antihistamines/allergy remedies
- More innovation necessary amid intensifying competition, while ageing population will help to sustain sales
- Growing preference among local consumers for natural remedies
- CATEGORY DATA
- Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
- Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
- Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
- Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
- Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
- Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
- DIGESTIVE REMEDIES IN FRANCE
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Robust growth results from consumer stress and sharp price hikes
- Tourism boost helps motion sickness remedies, while Johnson & Johnson leads by a slight margin
- Focus on gut health and demand for probiotics present challenge to growth
- PROSPECTS AND OPPORTUNITIES
- Stress and ageing to maintain future category growth
- PPIs faces concerns over possible product misuse
- Natural alternatives pose threat to OTC remedies
- CATEGORY DATA
- Table 24 Sales of Digestive Remedies by Category: Value 2019-2024
- Table 25 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
- Table 26 NBO Company Shares of Digestive Remedies: % Value 2020-2024
- Table 27 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
- Table 28 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
- Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
- DERMATOLOGICALS IN FRANCE
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Dermatologicals deemed less important than other OTC offerings during times of financial uncertainty
- Growth driven by return to pre-pandemic patterns
- Stress and anxiety boost performance of hair loss treatments
- PROSPECTS AND OPPORTUNITIES
- Demographic and climate issues set to impact forecast performance
- Continuous challenge from unclear positioning for dermatologicals
- Under-exploited potential for vaginal antifungals, while medicated shampoos will maintain stable sales
- CATEGORY DATA
- Table 30 Sales of Dermatologicals by Category: Value 2019-2024
- Table 31 Sales of Dermatologicals by Category: % Value Growth 2019-2024
- Table 32 NBO Company Shares of Dermatologicals: % Value 2020-2024
- Table 33 LBN Brand Shares of Dermatologicals: % Value 2021-2024
- Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2021-2024
- Table 35 Forecast Sales of Dermatologicals by Category: Value 2024-2029
- Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
- NRT SMOKING CESSATION AIDS IN FRANCE
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Reimbursement remains key for category, limiting OTC penetration
- Oral formats dominate, while players focus on mobile apps
- Leading players take divergent approaches to boosting sales
- PROSPECTS AND OPPORTUNITIES
- Category will struggle over the forecast period
- E-vapour products remain a serious competitive threat
- Natural products unlikely to make any headway in NRT smoking cessation aids
- CATEGORY INDICATORS
- Table 37 Number of Smokers by Gender 2019-2024
- CATEGORY DATA
- Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
- Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024
- Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2020-2024
- Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2021-2024
- Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2024-2029
- Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2024-2029
- SLEEP AIDS IN FRANCE
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Sleep aids continues to reap benefits from consumer stress and anxiety
- Gummies gain rapid ground
- Sanofi’s Novanuit remains overall leader
- PROSPECTS AND OPPORTUNITIES
- Demand set to continue throughout forecast period, despite challenges ahead
- Possible new competition from other consumer health options
- Potential for expansion in sea magnesium, melatonin and CBD
- CATEGORY DATA
- Table 44 Sales of Sleep Aids: Value 2019-2024
- Table 45 Sales of Sleep Aids: % Value Growth 2019-2024
- Table 46 NBO Company Shares of Sleep Aids: % Value 2020-2024
- Table 47 LBN Brand Shares of Sleep Aids: % Value 2021-2024
- Table 48 Forecast Sales of Sleep Aids: Value 2024-2029
- Table 49 Forecast Sales of Sleep Aids: % Value Growth 2024-2029
- EYE CARE IN FRANCE
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Increase in pollen and airborne allergens boost category performance
- Modern lifestyles also aid performance
- Competitive landscape remains stable
- PROSPECTS AND OPPORTUNITIES
- Rising prevalence of myopia in France
- Demand for eye care to forge ahead over the forecast period
- OTC eye care evolves amid ophthalmologist shortages
- CATEGORY DATA
- Table 50 Sales of Eye Care by Category: Value 2019-2024
- Table 51 Sales of Eye Care by Category: % Value Growth 2019-2024
- Table 52 NBO Company Shares of Eye Care: % Value 2020-2024
- Table 53 LBN Brand Shares of Eye Care: % Value 2021-2024
- Table 54 Forecast Sales of Eye Care by Category: Value 2024-2029
- Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2024-2029
- WOUND CARE IN FRANCE
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Poor performance for wound care in 2024
- URGO maintains leadership of overall wound care
- Ongoing threat to pharmacies from grocery retail
- PROSPECTS AND OPPORTUNITIES
- Maturity contributes to forecast disappointing performance
- Pure online and private label players hold further growth potential
- Limited room for growth in products with value-added features
- CATEGORY DATA
- Table 56 Sales of Wound Care by Category: Value 2019-2024
- Table 57 Sales of Wound Care by Category: % Value Growth 2019-2024
- Table 58 NBO Company Shares of Wound Care: % Value 2020-2024
- Table 59 LBN Brand Shares of Wound Care: % Value 2021-2024
- Table 60 Forecast Sales of Wound Care by Category: Value 2024-2029
- Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2024-2029
- VITAMINS IN FRANCE
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Return to pre-pandemic trends for vitamins in France
- Multivitamins too expensive for many, as vitamin D recovers from previous year’s dip
- Bayer rises in 2024
- PROSPECTS AND OPPORTUNITIES
- Growth set to continue during forecast period, benefitting from dietary trends
- Multivitamin growth to stay stable
- Vitamin D recommendation expected to accelerate growth
- CATEGORY DATA
- Table 62 Sales of Vitamins by Category: Value 2019-2024
- Table 63 Sales of Vitamins by Category: % Value Growth 2019-2024
- Table 64 Sales of Multivitamins by Positioning: % Value 2019-2024
- Table 65 NBO Company Shares of Vitamins: % Value 2020-2024
- Table 66 LBN Brand Shares of Vitamins: % Value 2021-2024
- Table 67 Forecast Sales of Vitamins by Category: Value 2024-2029
- Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2024-2029
- DIETARY SUPPLEMENTS IN FRANCE
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Another strong year of growth as consumers continue to opt for natural fixes
- Category-wide dynamism is thanks to the promise of functional ingredients
- Dermapharm leads while BMS enters the category with innovative offering
- PROSPECTS AND OPPORTUNITIES
- Favourable outlook thanks to increased focus on more natural products
- Social media activity expected to drive growth
- Pharmacies likely to reinforce leadership, as players focus more on benefits of eye health products
- CATEGORY DATA
- Table 69 Sales of Dietary Supplements by Category: Value 2019-2024
- Table 70 Sales of Dietary Supplements by Category: % Value Growth 2019-2024
- Table 71 Sales of Dietary Supplements by Positioning: % Value 2019-2024
- Table 72 NBO Company Shares of Dietary Supplements: % Value 2020-2024
- Table 73 LBN Brand Shares of Dietary Supplements: % Value 2021-2024
- Table 74 Forecast Sales of Dietary Supplements by Category: Value 2024-2029
- Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2024-2029
- WEIGHT MANAGEMENT AND WELLBEING IN FRANCE
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Weight management and wellbeing continues to suffer in 2024
- Evolving demand undermines interest in traditional category products
- Detox, drainage and gummies
- PROSPECTS AND OPPORTUNITIES
- Category faces difficult road ahead
- Customised coaching and new approaches
- Ongoing development for supplement nutrition and slimming teas
- CATEGORY DATA
- Table 76 Sales of Weight Management and Wellbeing by Category: Value 2019-2024
- Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2019-2024
- Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2020-2024
- Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2021-2024
- Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2024-2029
- Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2024-2029
- SPORTS NUTRITION IN FRANCE
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Growth driven rising numbers of athletes interested in endurance sports and fitness
- Explosion of gyms versus running and home-based training
- Mainstream players face a new generation of competitors
- PROSPECTS AND OPPORTUNITIES
- Plenty of room for growth in a still-evolving market
- Players to focus on finding new target audiences
- Anticipated influx of new products and formats
- CATEGORY DATA
- Table 82 Sales of Sports Nutrition by Category: Value 2019-2024
- Table 83 Sales of Sports Nutrition by Category: % Value Growth 2019-2024
- Table 84 NBO Company Shares of Sports Nutrition: % Value 2020-2024
- Table 85 LBN Brand Shares of Sports Nutrition: % Value 2021-2024
- Table 86 Forecast Sales of Sports Nutrition by Category: Value 2024-2029
- Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2024-2029
- HERBAL/TRADITIONAL PRODUCTS IN FRANCE
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- French consumers continue to shift towards herbal/traditional products
- Sleep issues and stress support sales, as natural trends gain traction
- Dermapharm as leading GBO through acquisition of Laboratoires Arkopharma, and demand for CBD-based variants rises rapidly
- PROSPECTS AND OPPORTUNITIES
- Ongoing favourable outlook for herbal/traditional products
- NRT smoking cessation aids unlikely to be impacted by herbal and natural trends
- Rising digestive complaints will support further category growth
- CATEGORY DATA
- Table 88 Sales of Herbal/Traditional Products by Category: Value 2019-2024
- Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2019-2024
- Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2020-2024
- Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2021-2024
- Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2024-2029
- Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2024-2029
- PAEDIATRIC CONSUMER HEALTH IN FRANCE
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Ambivalent performance from paediatric consumer health in 2024
- Non-chemical lice treatments gain momentum
- Naturalness trend spreads throughout overall category
- PROSPECTS AND OPPORTUNITIES
- Changing demographics present challenges to growth
- Rising demand for paediatric vitamins and dietary supplements with natural positioning
- Paediatric consumer health to be further affected by shortages
- CATEGORY DATA
- Table 94 Sales of Paediatric Consumer Health by Category: Value 2019-2024
- Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024
- Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2020-2024
- Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2021-2024
- Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2024-2029
- Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2024-2029
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook